Other languages Beijing SL Pharmaceutical Co., Ltd.

Equities

002038

CNE000001L31

End-of-day quote Shenzhen S.E. Other stock markets 03:30:00 16/05/2024 am IST			5-day change	1st Jan Change
8.45 ^CNY	-0.47%		-5.69%	-17.08%

24/04	Beijing SL Pharmaceutical Co., Ltd. Proposes Final Cash Dividend for 2023	CI
23/04	Beijing SL Pharmaceutical Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024	CI

Other languages

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Beijing SL Pharmaceutical Co., Ltd. Proposes Final Cash Dividend for 2023	24/04
Beijing SL Pharmaceutical Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024	23/04
Beijing SL Pharmaceutical Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2023	25/23/25
Chinese Shares Extend Losses on Middle East Conflict; Beijing SL Pharmaceutical Slumps Despite Drug Trial Approval	20/23/20
Beijing SL Pharmaceutical Gets Nod to Trial Anti-Hepatitis C Drug; Shares Drop 10%	20/23/20
Kanghui Pharma Denies Speculations of Unit’s Involvement in Production of Weight-Loss Drugs	17/23/17
Beijing SL Pharmaceutical Gets Certificate for PEGylated Human Granulocyte Stimulating Factor Injection; Shares Up 3%	25/23/25
Beijing SL Pharmaceutical Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2023	24/23/24
Beijing SL Pharma Gets Registration Certificate for Cancer Drug	20/23/20
Beijing SL Pharmaceutical Co., Ltd. Approves Final Cash Dividend for the Year 2022, Payable on 28 June 2023	27/23/27
Beijing Sl Pharmaceutical Co., Ltd. Proposes Final Cash Dividend for 2022	27/23/27
Beijing SL Pharmaceutical Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2023	25/23/25
Beijing SL Pharmaceutical Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2022	25/23/25
Beijing SL Pharma Registers Diabetes Drug	23/23/23
Beijing SL Pharmaceutical's Flu Medicine Gets Marketing Nod in China	23/22/23
Beijing SL Pharmaceutical Gets Regulatory Approval for Argatroban Injection	08/22/08
Beijing SL Pharmaceutical Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2022	25/22/25
Beijing SL Pharmaceutical Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2022	23/22/23
Beijing SL Pharmaceutical Co., Ltd. Implements Final Dividend on Share A for 2021, Payable on June 29, 2022	23/22/23
Beijing SL Pharmaceutical Co., Ltd. Approves Cash Dividend for the Year 2021	28/22/28

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Other languages Beijing SL Pharmaceutical Co., Ltd.

Equities

002038

CNE000001L31

Other languages

Filters